News & Events about Omnicell Inc.
Omnicell, Inc. (NASDAQ:OMCL Get Rating) Director Joanne B. Bauer sold 13,115 shares of the businesss stock in a transaction dated Tuesday, March 7th. The shares were sold at an average price of $54.24, for a total value of $711,357.60. Following the completion of the sale, the ...
Omnicell (NASDAQ:OMCL Get Rating) had its price objective reduced by KeyCorp from $75.00 to $70.00 in a research note released on Thursday morning, The Fly reports. KeyCorp currently has an overweight rating on the stock. Several other equities analysts have also recently issued reports on OMCL. ...
Omnicell (NASDAQ:OMCL Get Rating) had its price objective decreased by KeyCorp from $75.00 to $70.00 in a research report sent to investors on Thursday morning, The Fly reports. KeyCorp currently has an overweight rating on the stock. A number of other research firms also recently issued ...
Ticker Report
3 months ago
Omnicell, Inc. (NASDAQ:OMCL Get Rating) EVP Scott Peter Seidelmann sold 4,436 shares of the businesss stock in a transaction on Friday, December 16th. The stock was sold at an average price of $47.79, for a total value of $211,996.44. Following the sale, the executive vice president ...
Business Wire
3 months ago
Omnicell, Inc. (Nasdaq: OMCL) (Omnicell or the Company), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that it will showcase the Companys Advanced Services at this years American Society of Health-System Pharmacists...